Cargando…

MOGAT2: A New Therapeutic Target for Metabolic Syndrome

Metabolic syndrome is an ever-increasing health problem among the world’s population. It is a group of intertwined maladies that includes obesity, hypertriglyceridemia, hypertension, nonalcoholic fatty liver disease (NAFLD), and diabetes mellitus type II (T2D). There is a direct correlation between...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Muhua, Nickels, Joseph T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548241/ https://www.ncbi.nlm.nih.gov/pubmed/28943619 http://dx.doi.org/10.3390/diseases3030176

Ejemplares similares

Multiple antisense oligonucleotides targeted against monoacylglycerol acyltransferase 1 (Mogat1) improve glucose metabolism independently of Mogat1
por: Lutkewitte, Andrew J., et al.
Publicado: (2021)

Assessment of the association of the MOGAT1 and MOGAT3 gene with growth traits in different growth stages in Holstein calves
por: Gökçe, Gökhan, et al.
Publicado: (2022)

Copy Number Variations in the MICALL2 and MOGAT2 Genes Are Associated with Ashidan Yak Growth Traits
por: Liu, Modian, et al.
Publicado: (2022)

DGAT2-MOGAT2 SNPs and Gene-Environment Interactions on Serum Lipid Profiles and the Risk of Ischemic Stroke
por: Zhou, Yong-Gang, et al.
Publicado: (2021)

Polymorphisms and genetic effects of PRLR, MOGAT1, MINPP1 and CHUK genes on milk fatty acid traits in Chinese Holstein
por: Shi, Lijun, et al.
Publicado: (2019)

Characterization of the Mouse and Human Monoacylglycerol O-Acyltransferase 1 (Mogat1) Promoter in Human Kidney Proximal Tubule and Rat Liver Cells
por: Sankella, Shireesha, et al.
Publicado: (2016)

Carotid Body and Metabolic Syndrome: Mechanisms and Potential Therapeutic Targets
por: Kim, Lenise J., et al.
Publicado: (2020)

Macrophage MicroRNAs as Therapeutic Targets for Atherosclerosis, Metabolic Syndrome, and Cancer
por: Wei, Yuanyuan, et al.
Publicado: (2018)

Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease?
por: Fisman, Enrique Z, et al.
Publicado: (2014)

Podocyte RhoGTPases: new therapeutic targets for nephrotic syndrome?
por: Saleem, Moin A., et al.
Publicado: (2019)

TREM2 in the pathogenesis of AD: a lipid metabolism regulator and potential metabolic therapeutic target
por: Li, Rui-Yang, et al.
Publicado: (2022)

Myostatin: a potential therapeutic target for metabolic syndrome
por: Yang, Ming, et al.
Publicado: (2023)

Metabolic syndrome: new therapeutic approaches
por: Della Corte, Claudia, et al.
Publicado: (2014)

Targeting Metabolic Syndrome in Hidradenitis Suppurativa by Phytochemicals as a Potential Complementary Therapeutic Strategy
por: Witte, Katrin, et al.
Publicado: (2023)

Cancer Metabolism: Phenotype, Signaling and Therapeutic Targets
por: Park, Jae Hyung, et al.
Publicado: (2020)

Targeting Mitochondrial Metabolic Dysfunction in Pulmonary Hypertension: Toward New Therapeutic Approaches?
por: Riou, Marianne, et al.
Publicado: (2023)

Autophagy Dysregulation in Metabolic Associated Fatty Liver Disease: A New Therapeutic Target
por: Chen, Chun-Liang, et al.
Publicado: (2022)

COVID‐19 metabolism: Mechanisms and therapeutic targets
por: Wang, Tianshi, et al.
Publicado: (2022)

New therapeutic targets for cancer: the interplay between immune and metabolic checkpoints and gut microbiota
por: Agrawal, Babita
Publicado: (2019)

Tumor Microenvironment-Derived Metabolites: A Guide to Find New Metabolic Therapeutic Targets and Biomarkers
por: García-Cañaveras, Juan C., et al.
Publicado: (2021)

Acetyl-CoA Synthetase 2 as a Therapeutic Target in Tumor Metabolism
por: Liu, Mengfang, et al.
Publicado: (2022)

Targeting cellular metabolism to improve cancer therapeutics
por: Zhao, Y, et al.
Publicado: (2013)

Cancer cell metabolism: implications for therapeutic targets
por: Jang, Miran, et al.
Publicado: (2013)

Targeting Lipid Metabolic Reprogramming as Anticancer Therapeutics
por: Cha, Ji-Young, et al.
Publicado: (2016)

Oncology Therapeutics Targeting the Metabolism of Amino Acids
por: Muhammad, Nefertiti, et al.
Publicado: (2020)

Ceramide Metabolism and Parkinson’s Disease—Therapeutic Targets
por: Custodia, Antía, et al.
Publicado: (2021)

Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma
por: Pang, Yuyang, et al.
Publicado: (2023)

Recent Progress in Metabolic Syndrome Research and Therapeutics
por: Kao, Ting-Wei, et al.
Publicado: (2021)

Cholesterol Metabolism: A Potential Therapeutic Target in Glioblastoma
por: Ahmad, Fahim, et al.
Publicado: (2019)

INDY as a Therapeutic Target for Cardio-Metabolic Disease
por: Pesta, Dominik, et al.
Publicado: (2022)

Cancer Metabolism as a Therapeutic Target and Review of Interventions
por: Halma, Matthew T. J., et al.
Publicado: (2023)

New dimension in therapeutic targeting of BCL-2 family proteins
por: Besbes, Samaher, et al.
Publicado: (2015)

SIRT2 as a potential new therapeutic target for Alzheimer’s disease
por: Sola-Sevilla, Noemi, et al.
Publicado: (2023)

Advances in rheumatology: new targeted therapeutics
por: Tak, Paul P, et al.
Publicado: (2011)

Myeloid derived suppressor cells – a new therapeutic target in the treatment of cancer
por: Wesolowski, Robert, et al.
Publicado: (2013)

Interleukin-6: a new therapeutic target
por: Smolen, Josef S, et al.
Publicado: (2006)

Iron Metabolism: An Emerging Therapeutic Target in Critical Illness
por: Litton, Edward, et al.
Publicado: (2019)

Can Metabolic Pathways Be Therapeutic Targets in Rheumatoid Arthritis?
por: Sanchez-Lopez, Elsa, et al.
Publicado: (2019)

PPARs as Metabolic Sensors and Therapeutic Targets in Liver Diseases
por: Monroy-Ramirez, Hugo Christian, et al.
Publicado: (2021)

Ceramide Metabolism Enzymes—Therapeutic Targets against Cancer
por: Gomez-Larrauri, Ana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_84sjg029ufui3ghtbtfib4tiub